EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Wanjia Group Holdings Ltd (0401) fair value: what the stock is really worth

As of Sep 29, 2026: fair value of Wanjia Group Holdings Ltd HK$0.12, price HK$0.10, upside +26.3%, quality 61 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · HK · ISIN KYG9431A1186

WG Thin data Sep 27, 2026

Wanjia Group Holdings Ltd

0401 · HK

UndervaluedThe stock appears undervalued with acceptable quality.

✓Fair value HK$0.1200 · Undervalued (+26.3%)
✓Quality 61/100
!Mixed Growth (revenue 5y +10.8 %/yr)
!Loss-making · -5.2% net margin (TTM)
✓Low debt · generates free cash flow
✓Ranks above peers (7/11)
!Narrow moat 4/100
!Evidence only low, so the estimate is less certain
!Weak on future: 12 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

HK$0.6486 HK$0.0380 Fair Value HK$0.1200 Apr 2018 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.

How to read this chart

60‑month range HK$0.0380 – HK$0.6486 · fair‑value band HK$0.1000 – HK$0.1400 · the HK$0.0950 price screens below the HK$0.1200 fair value. Dashed = 300-day average. As of Sep 27, 2026.

Follow Wanjia Group Holdings in your weekly email

Every Wednesday you see whether Wanjia Group Holdings is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Wanjia Group Holdings Limited, an investment holding company, engages in the wholesale and distribution pharmaceutical business in the Mainland China and Hong Kong. The company offers hemodialysis treatment and consultancy services.

Show more

Wanjia Group Holdings Limited, an investment holding company, engages in the wholesale and distribution pharmaceutical business in the Mainland China and Hong Kong. The company offers hemodialysis treatment and consultancy services. It sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics. Wanjia Group Holdings Limited was founded in 2004 and is headquartered in Kowloon, Hong Kong.

Stock analysis

Wanjia Group Holdings Ltd (0401) currently trades at HK$0.0950, while our model-based Fair Value estimate is HK$0.1200, implying the stock looks roughly 20.8% undervalued today.

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of HK$0.1400 per share, and 7 of the 11 models we run sit above the HK$0.0950 price.

Bear case: the Asset-Based group reads lowest at HK$0.0400, and 4 of the 11 models stay below the price. Evidence for this calculation is low.

Scenario range: HK$0.1000 (bear) to HK$0.1400 (bull), the price of HK$0.0950 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 61/100 (solid quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Wanjia Group Holdings Ltd reported revenue of HK$162M in FY2025 versus HK$114M in FY2021, a compound +9.1%/yr. Reported net income was −HK$6.6M in FY2025.

Key figures

Market cap HK$142M (≈ $18.1M) · P/S ratio 0.87 · EPS (TTM) HK$−0.0100 · Net margin −4.1% · Return on equity −11.9% · Return on assets (EBIT) −12.1% · Operating margin 0.9% · Revenue (TTM) HK$164M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).

What moves the price

The share trades about 53% below its 52-week high and 26% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 37% fair-value upside, at 26%, 0401 screens richer than that median.

Fair Value models

Bear HK$0.1000 Fair Value HK$0.1200 Bull HK$0.1400
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF HK$0.1100 HK$0.1400 HK$0.2000 81
Growth DCF HK$0.1200 HK$0.1400 HK$0.1900 80
Owner Earnings HK$0.0400 HK$0.0400 HK$0.0500 78
All 11 models by family
DCF Models
FCF DCF HK$0.1100 HK$0.1400 HK$0.2000 81
Owner Earnings HK$0.0400 HK$0.0400 HK$0.0500 78
5Y Revenue Exit HK$0.1000 HK$0.1400 HK$0.1900 73
5Y EBITDA Exit HK$0.0800 HK$0.0900 HK$0.1200 77
10Y Revenue Exit HK$0.1000 HK$0.1300 HK$0.1600 68
10Y EBITDA Exit HK$0.0900 HK$0.1000 HK$0.1200 70
Multiples
EV/EBITDA HK$0.0600 HK$0.0700 HK$0.0900 67
EV/Revenue HK$0.1000 HK$0.1400 HK$0.1700 54
Asset-Based
NCAV (Graham) HK$0.0300 HK$0.0400 HK$0.0600 54
Growth DCF
Growth DCF HK$0.1200 HK$0.1400 HK$0.1900 80
Rev-Margin DCF HK$0.1000 HK$0.1400 HK$0.1800 74

Open the full fair value analysis →

Notify me when 0401 reaches fair value

Put 0401 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 61/100

Of which business quality 63 · Market factors (momentum, volatility) 37

Profitability 37
Margins and returns on capital today
Quality Growth 59
Are margins and returns improving?
Cashflow 56
Earnings quality: real cash, not paper profit
Fin. Strength 68
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 18
Calm price path (market factor)
Momentum 41
Price trend over the last 3–12 months (market factor)
52W Momentum 50
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 49/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−10.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.8%
Start year 2020 (pandemic). Over 10 years: −20.3% a year
Revenue growth 14 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−14.1%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−9.8% (2020) → −2.5% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−23.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Hong Kong: IMF forecast 2.1% a year to 2030, 1.8% from 2016 to 2025) that is about −24.8% a year for the price.

Watch 0401, get fair value alerts →

Compare Wanjia Group Holdings Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Distribution · 78 stocks

Beats the industry median on 6/9 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 61 · Top 25%
Fair Value upside +26.3% · Above median
Profitability
Return on assets −3.0% · Bottom 25%
Net margin (TTM) −5.2% · Bottom 25%
Operating margin (TTM) 0.9% · Bottom 25%
Growth and dividend
Revenue growth 2.4% · Above median

Valuation Multiplesvs Medical Distribution median · lower = cheaper

P/B 0.27× · Cheapest 25%
P/S (TTM) 0.11× · Cheapest 25%
P/FCF 1.8× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)68 · sector 39
FUTURE (revenue growth)12 · sector 12
PAST (return on equity)0 · sector 26
HEALTH (low debt)100 · sector 97
DIVIDEND (yield)0 · sector 58

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Distribution stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
McKesson Corporation MCK $866.64 $822.74 −5%
Cencora, Inc COR $306.92 $215.20 −30%
Cardinal Health, Inc CAH $220.29 $162.84 −26%
Henry Schein, Inc HSIC $86.37 $76.77 −11%
Shanghai Pharmaceuticals Holding 601607 ¥16.02 ¥42.67 +166%
Sinopharm Group 1099 HK$14.88 HK$55.77 +275%
Galenica AG GALE CHF 82.55 CHF 61.79 −25%
Guangzhou Baiyunshan Pharmaceutical Holdings 600332 ¥19.39 ¥26.64 +37%
Jointown Pharmaceutical Group 600998 ¥4.93 ¥9.84 +100%
China National Medicines Corporation 600511 ¥25.80 ¥58.47 +127%

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Wanjia Group Holdings Ltd Fair Value". https://www.fairvalue-calculator.com/stock/0401

Frequently asked questions

Is Wanjia Group Holdings Ltd (0401) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of HK$0.1200 versus a price of HK$0.0950, about +26% upside (undervalued).
What is the fair value of 0401?
Our model-based fair value for Wanjia Group Holdings Ltd is HK$0.1200 (as of Sep 27, 2026), built from audited fundamentals. The current price: HK$0.0950.
What is the quality score of 0401?
Wanjia Group Holdings Ltd has a Quality Score of 61/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Wanjia Group Holdings Ltd (0401)?
Our model-based price target is the fair value of HK$0.1200 (as of Sep 27, 2026) from 11 valuation models. Cautious scenario HK$0.1000, optimistic scenario HK$0.1400. It is a calculation from audited fundamentals, not an analyst target.
What is the Wanjia Group Holdings Ltd stock forecast for 2026?
Our models put fair value at HK$0.1200, about +26% upside versus a price of HK$0.0950 (undervalued). Cautious scenario HK$0.1000, optimistic scenario HK$0.1400. The calculation is refreshed regularly with new filings.
What is the revenue of Wanjia Group Holdings Ltd (0401)?
Wanjia Group Holdings Ltd reported trailing-twelve-month revenue of about HK$164M (latest available figure, as of Sep 27, 2026).
What growth is priced into Wanjia Group Holdings Ltd (0401)?
For today's price to be fair in a discounted-cash-flow model, Wanjia Group Holdings Ltd would have to grow free cash flow by -23.2 % per year for five years (discount rate 11.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +10.8 % per year. As of Sep 27, 2026.
What discount rate (WACC) does the fair value of 0401 use?
Our models discount Wanjia Group Holdings Ltd at 11.2 %: a base by market capitalisation (nano), damped by beta 1.34, country premium for Hong Kong. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Wanjia Group Holdings Ltd that is -23.2 % per year a year over ten years, using the same discount rate (11.2 %) and the same formula as our fair value.
How much growth has Wanjia Group Holdings Ltd (0401) delivered so far?
Over the past 5 years revenue at Wanjia Group Holdings Ltd grew +10.8 % a year. The price currently implies -23.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Wanjia Group Holdings Ltd (0401) growing?
The median revenue growth in the sector is +4.3 % a year. That is the yardstick for the growth priced into Wanjia Group Holdings Ltd (-23.2 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Wanjia Group Holdings Ltd (0401)?
The free-cash-flow yield on the price is 18.64 %: that much free cash flow Wanjia Group Holdings Ltd produces per unit of market value. When it exceeds the discount rate of our models (11.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Wanjia Group Holdings Ltd (0401)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Wanjia Group Holdings Ltd it is HK$0.1200 per share (as of Sep 27, 2026), against a price of HK$0.0950. It is the blended result of 11 valuation models (cash flow, earnings, asset, dividend).
Is Wanjia Group Holdings Ltd stock overvalued or undervalued in 2026?
As of Sep 27, 2026, 0401 trades below its calculated fair value: price HK$0.0950, fair value HK$0.1200, a gap of about +26% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0401?
No. The price is what the market pays today (HK$0.0950); the fair value is what the company's own numbers justify (HK$0.1200). For Wanjia Group Holdings Ltd the two are HK$0.0250 per share apart. That gap is exactly why we show both numbers side by side.
How much is Wanjia Group Holdings Ltd worth?
The market values Wanjia Group Holdings Ltd at about HK$142M (market capitalisation, as of Sep 27, 2026). Per share that is HK$0.0950; our models calculate a fair value of HK$0.1200 per share.
What do the bullish and bearish scenarios say about 0401?
Our models span a range for Wanjia Group Holdings Ltd: cautious scenario HK$0.1000, base HK$0.1200, optimistic HK$0.1400 per share (as of Sep 27, 2026, price HK$0.0950). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Wanjia Group Holdings Ltd (0401)?
Balance-sheet figures for Wanjia Group Holdings Ltd (as of Sep 27, 2026): return on equity −11.9%. They feed the Quality Score of 61/100, which measures business quality independently of the share price.
How far is 0401 from its 52-week high?
Wanjia Group Holdings Ltd trades at HK$0.0950, about 53% below its 52-week high of HK$0.2020 and 26% above the low of HK$0.0751 (as of Sep 29, 2026). Distance from the high says nothing about value: that is what the fair value of HK$0.1200 is for.
Which stocks are comparable to Wanjia Group Holdings Ltd?
From the same area (Healthcare) we also value McKesson Corporation, Cencora, Inc, Cardinal Health, Inc, Henry Schein, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Wanjia Group Holdings Ltd stock attractive at the current price?
The data as of Sep 27, 2026: price HK$0.0950, calculated fair value HK$0.1200 (+26%), Quality Score 61/100, from 11 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 0401 calculated?
We run Wanjia Group Holdings Ltd through 11 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of HK$0.1200, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.9 % above its aggregate fair value. Wanjia Group Holdings Ltd currently trades 21 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Wanjia Group Holdings Ltd (0401)?
The closing price on Sep 29, 2026 was HK$0.0950. Our model-based fair value is HK$0.1200, about +26% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Wanjia Group Holdings Ltd right now?
The price is below even our cautious bear case (HK$0.1000). The market is more pessimistic than our downside scenario. Solid quality (61/100) at a price below fair value, the discount is the argument here, not the business quality. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Wanjia Group Holdings Ltd

How large is the market capitalisation of Wanjia Group Holdings Ltd (0401)?
The market capitalisation of Wanjia Group Holdings Ltd is HK$142M (≈ $18.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Wanjia Group Holdings Ltd (0401)?
The price-to-sales ratio of Wanjia Group Holdings Ltd is 0.87 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Wanjia Group Holdings Ltd (0401)?
Earnings per share at Wanjia Group Holdings Ltd are HK$−0.0100. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Wanjia Group Holdings Ltd (0401)?
The net margin of Wanjia Group Holdings Ltd is −4.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Wanjia Group Holdings Ltd (0401)?
The return on equity (ROE) of Wanjia Group Holdings Ltd is −11.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Wanjia Group Holdings Ltd (0401)?
On an EBIT basis the return on assets of Wanjia Group Holdings Ltd is −12.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Wanjia Group Holdings Ltd (0401)?
The operating margin of Wanjia Group Holdings Ltd is 0.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Wanjia Group Holdings Ltd (0401)?
Revenue at Wanjia Group Holdings Ltd is growing +2.4% versus a year earlier (3y avg +1.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net cash does Wanjia Group Holdings Ltd (0401) hold?
Wanjia Group Holdings Ltd holds more cash than debt, HK$12.4M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Wanjia Group Holdings Ltd in the live analysis

One click puts Wanjia Group Holdings Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.